Search

Your search keyword '"Lasky, J"' showing total 178 results
Start Over Author "Lasky, J"
178 results on '"Lasky, J"'

2. Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis

Author

Maher, TM, Ford, P, Brown, KK, Costabel, U, Cottin, V, Danoff, SK, Groenveld, I, Helmer, E, Jenkins, RG, Milner, J, Molenberghs, G, Penninckx, B, Randall, MJ, Van Den Blink, B, Fieuw, A, Vandenrijn, C, Rocak, S, Seghers, I, Shao, L, Taneja, A, Jentsch, G, Watkins, TR, Wuyts, WA, Kreuter, M, Verbruggen, N, Prasad, N, Wijsenbeek, MS, Chambers, D, Chia, M, Corte, T, Glaspole, I, Goh, N, Holmes, M, Malouf, M, Thien, F, Veitch, E, Bondue, B, Dahlqvist, C, Froidure, A, Slabbynck, H, Wuyts, W, Cartagena Salinas, C, Feijoó Seoane, R, Martínez, V, Maturana, R, Pavie Gallegos, J, Rosenblut, A, Silva, R, Undurraga Pereira, A, Doubkova, M, Pauk, N, Plackova, M, Sterclova, M, Bendstrup, E, Shaker, SB, Titlestad, I, Budweiser, S, Grohé, C, Koschel, D, Prasse, A, Weber, M, Wirtz, H, Antoniou, K, Daniil, Z, Gaga, M, Papakosta, D, Izumi, S, Okamoto, M, Guerreros Benavides, A, Iberico Barrera, C, Peña Villalobos, AM, Campo Ezquibela, A, Cifrian Martinez, JM, Fernandez Fabrellas, E, Leiro, V, Molina-Molina, M, Nieto Barbero, A, Sellares Torres, J, Valenzuela, C, Cheng, S-L, Kuo, P-H, Lee, K-Y, Sheu, C-C, Gunen, H, Mogulkoc Bishop, N, Nayci, S, Adamali, H, Bianchi, S, Chaudhuri, N, Gibbons, M, Hart, S, Molyneaux, P, Parfrey, H, Saini, G, Spencer, LG, Wiscombe, S, Antin-Ozerkis, D, Bascom, R, Belperio, J, Britt, E, Fitzgerald, J, Gomez Manjarres, D, Gotfried, M, Gupta, N, Hotchkin, D, Kaye, M, Kreider, M, Kureishy, S, Lacamera, P, Lancaster, L, Lasky, J, Lorch, D, Mannem, H, Morrow, L, Moua, T, Nambiar, A, Raghu, G, Raj, R, Ramaswamy, M, Reddy, R, Russell, T, Scholand, MB, Shea, B, Suliman, S, Swigris, J, Thavarajah, K, Tolle, L, Tomic, R, Warshoff, N, Wesselius, L, Yung, G, Bergna, M, De Salvo, M, Fernandez Acquier, M, Rodriguez, A, Saez Scherbovsky, P, Assayag, D, Dhar, A, Khalil, N, Morisset, J, Provencher, S, Ryerson, C, Shapera, S, Bourdin, A, Crestani, B, Lebargy, F, Reynaud-Gaubert, M, Bonella, FT, Claussen, M, Hammerl, P, Karagiannidis, C, Keller, C, Randerath, W, Stubbe, B, Csánky, E, Medgyasszay, B, Muller, V, Adir, Y, Bar-Shai, A, Berkman, N, Fink, G, Kramer, M, Shitrit, D, Bargagli, E, Gasparini, S, Harari, S, Ravaglia, C, Richeldi, L, Vancheri, C, Ebina, M, Fujita, M, Ichikado, K, Inoue, Y, Ishikawa, N, Kato, M, Kawamura, T, Kondoh, Y, Nishioka, Y, Ogura, T, Owan, I, Saito, T, Sakamoto, N, Sakamoto, K, Shirai, M, Suda, T, Tomii, K, Chung, MP, Jeong, SH, Park, CS, Park, JS, Song, JW, Uh, S-T, Chavarria Martinez, U, Montano Gonzalez, E, Ramirez, A, Selman Lama, ME, Bresser, P, Kramer, H, Mostard, R, Nossent, E, Veltkamp, M, Wijsenbeek, M, Beckert, L, Chang, CL, Veale, A, Wilsher, M, Bednarek, M, Gasior, G, Jasieniak-Pinis, G, Jassem, E, Mroz, R, Piotrowski, W, Abdullah, I, Ambaram, A, Irusen, E, Van der Linden, M, Van Zyl-Smit, R, Williams, P, Allen, J, Averill, F, Belloli, E, Brown, A, Case, A, Chaudhary, S, Criner, G, DeBoer, K, Dilling, D, Dorf, J, Enelow, R, Ettinger, N, Feldman, J, Gibson, K, Golden, J, Hamblin, M, Hunninghake, G, Karunakara, R, Kim, H, Luckhardt, T, Menon, P, Morrison, L, Oldham, J, Patel, N, Schmidt, S, Strek, M, Summer, R, Sussman, R, Tita, J, Veeraraghavan, S, Whelan, T, and Zibrak, J

Abstract

Importance There is a major need for effective, well-tolerated treatments for idiopathic pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor ziritaxestat in patients with IPF. Design, Setting, and Participants The 2 identically designed, phase 3, randomized clinical trials, ISABELA 1 and ISABELA 2, were conducted in Africa, Asia-Pacific region, Europe, Latin America, the Middle East, and North America (26 countries). A total of 1306 patients with IPF were randomized (525 patients at 106 sites in ISABELA 1 and 781 patients at 121 sites in ISABELA 2). Enrollment began in November 2018 in both trials and follow-up was completed early due to study termination on April 12, 2021, for ISABELA 1 and on March 30, 2021, for ISABELA 2. Interventions Patients were randomized 1:1:1 to receive 600 mg of oral ziritaxestat, 200 mg of ziritaxestat, or placebo once daily in addition to local standard of care (pirfenidone, nintedanib, or neither) for at least 52 weeks. Main Outcomes and Measures The primary outcome was the annual rate of decline for forced vital capacity (FVC) at week 52. The key secondary outcomes were disease progression, time to first respiratory-related hospitalization, and change from baseline in St George’s Respiratory Questionnaire total score (range, 0 to 100; higher scores indicate poorer health-related quality of life). Results At the time of study termination, 525 patients were randomized in ISABELA 1 and 781 patients in ISABELA 2 (mean age: 70.0 [SD, 7.2] years in ISABELA 1 and 69.8 [SD, 7.1] years in ISABELA 2; male: 82.4% and 81.2%, respectively). The trials were terminated early after an independent data and safety monitoring committee concluded that the benefit to risk profile of ziritaxestat no longer supported their continuation. Ziritaxestat did not improve the annual rate of FVC decline vs placebo in either study. In ISABELA 1, the least-squares mean annual rate of FVC decline was –124.6 mL (95% CI, −178.0 to −71.2 mL) with 600 mg of ziritaxestat vs –147.3 mL (95% CI, −199.8 to −94.7 mL) with placebo (between-group difference, 22.7 mL [95% CI, −52.3 to 97.6 mL]), and –173.9 mL (95% CI, −225.7 to −122.2 mL) with 200 mg of ziritaxestat (between-group difference vs placebo, −26.7 mL [95% CI, −100.5 to 47.1 mL]). In ISABELA 2, the least-squares mean annual rate of FVC decline was –173.8 mL (95% CI, −209.2 to −138.4 mL) with 600 mg of ziritaxestat vs –176.6 mL (95% CI, −211.4 to −141.8 mL) with placebo (between-group difference, 2.8 mL [95% CI, −46.9 to 52.4 mL]) and –174.9 mL (95% CI, −209.5 to −140.2 mL) with 200 mg of ziritaxestat (between-group difference vs placebo, 1.7 mL [95% CI, −47.4 to 50.8 mL]). There was no benefit with ziritaxestat vs placebo for the key secondary outcomes. In ISABELA 1, all-cause mortality was 8.0% with 600 mg of ziritaxestat, 4.6% with 200 mg of ziritaxestat, and 6.3% with placebo; in ISABELA 2, it was 9.3% with 600 mg of ziritaxestat, 8.5% with 200 mg of ziritaxestat, and 4.7% with placebo. Conclusions and Relevance Ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care treatment with pirfenidone or nintedanib or in those not receiving standard of care treatment. Trial Registration ClinicalTrials.gov Identifiers: NCT03711162 and NCT03733444

Published
2023

3. Get the science right when paying for nature's services: Few projects adequately address design and evaluation

Author

Naeem, S., Ingram, J. C., Varga, A., Agardy, T., Barten, P., Bennett, G., Bloomgarden, E., Bremer, L. L., Burkill, P., Cattau, M., Ching, C., Colby, M., Cook, D. C., Costanza, R., DeClerck, F., Freund, C., Gartner, T., Goldman-Benner, R., Gunderson, J., Jarrett, D., Kinzig, A. P., Kiss, A., Koontz, A., Kumar, P., Lasky, J. R., Masozera, M., Meyers, D., Milano, F., Naughton-Treves, L., Nichols, E., Olander, L., Olmsted, P., Perge, E., Perrings, C., Polasky, S., Potent, J., Prager, C., Quétier, F., Redford, K., Saterson, K., Thoumi, G., Vargas, M. T., Vickerman, S., Weisser, W., Wilkie, D., and Wunder, S.

Published
2015

5. ENVIRONMENT AND DEVELOPMENT: Get the science right when paying for natureʼs services

Author

Naeem, S., Ingram, J. C., Varga, A., Agardy, T., Barten, P., Bennett, G., Bloomgarden, E., Bremer, L. L., Burkill, P., Cattau, M., Ching, C., Colby, M., Cook, D. C., Costanza, R., DeClerck, F., Freund, C., Gartner, T., Goldman-Benner, R., Gunderson, J., Jarrett, D., Kinzig, A. P., Kiss, A., Koontz, A., Kumar, P., Lasky, J. R., Masozera, M., Meyers, D., Milano, F., Naughton-Treves, L., Nichols, E., Olander, L., Olmsted, P., Perge, E., Perrings, C., Polasky, S., Potent, J., Prager, C., Quétier, F., Redford, K., Saterson, K., Thoumi, G., Vargas, M. T., Vickerman, S., Weisser, W., Wilkie, D., and Wunder, S.

Published
2015
Full Text
View/download PDF

10. Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

Author

Lasky, J. A., Criner, G. J., Lazarus, H. M., Kohlbrenner, V., Bender, S., Richeldi, Luca, Richeldi L. (ORCID:0000-0001-8594-1448), Lasky, J. A., Criner, G. J., Lazarus, H. M., Kohlbrenner, V., Bender, S., Richeldi, Luca, and Richeldi L. (ORCID:0000-0001-8594-1448)

Abstract

Introduction: The safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF) have been characterized using data from clinical trials. Methods: We further characterized the safety and tolerability of nintedanib in patients with IPF in clinical practice using the global pharmacovigilance database. The database included spontaneously reported adverse events and data collected via solicited reporting in patients treated with nintedanib from 15 October 2014 to 15 October 2018. Adverse events were coded using the Medical Dictionary for Regulatory Activities. Cumulative exposure to nintedanib was estimated on the basis of sales data. Results: Cumulative exposure to nintedanib was estimated as 60,107 patient-years. Diarrhea was the most frequent event (301.6 events per 1000 patient-years). Most (97.0%) diarrhea events were non-serious. The median (25th, 75th percentile) time to onset of the first diarrhea event was 60 (11, 182) days. Elevated liver enzyme or bilirubin levels were reported at a rate of 31.5 events per 1000 patient-years. Bleeding was reported at a rate of 36.8 events per 1000 patient-years; 81.0% of events were non-serious. Major cardiovascular adverse events were reported at a rate of 13.4 events per 1000 patient-years and myocardial infarction at a rate of 4.3 events per 1000 patient-years. Gastrointestinal perforation was reported at a rate of 1.0 event per 1000 patient-years. Conclusions: On the basis of pharmacovigilance data collected over 4 years, the safety profile of nintedanib in patients with IPF was consistent with that observed in clinical trials and described in the product label, with no new safety concerns observed. Graphical Abstract: [Figure not available: see fulltext.]

Published
2020

12. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

Author

Becker M, Graf N, Sauter R, Curram J, Denton C, Khanna D, Pena J, Pope J, Distler O, Matucci-Cerinic M, Guiducci S, Walker U, Jaeger V, Bannert B, Lapadula G, Becvarare R, Cutolo M, Valentini G, Siegert E, Rednic S, Allanore Y, Montecucco C, Carreira P, Novak S, Czirjak L, Varju C, Chizzolini C, Allai D, Kucharz E, Cozzi F, Rozman B, Mallia C, Gabrielli A, Bancel D, Airo P, Hesselstrand R, Martinovic D, Balbir-Gurman A, Braun-Moscovici Y, Hunzelmann N, Pellerito R, Caramaschi P, Black C, Damjanov N, Henes J, Santamaria V, Heitmann S, Seidel M, Da Silva J, Stamenkovic B, Selmi C, Tikly M, Denisov L, Muller-Ladner U, Engelhart M, Hachulla E, Riccieri V, Ionescu R, Mihai C, Sunderkotter C, Kuhn A, Schett G, Distler J, Meroni P, Ingegnoli F, Mouthon L, De Keyser F, Smith V, Cantatore F, Corrado A, Ullman S, Iversen L, Pozzi M, Eyerich K, Hein R, Knott E, Wiland P, Szmyrka-Kaczmarek M, Sokolik R, Morgiel E, Madej M, Alegre-Sancho J, Krummel-Lorenz B, Saar P, Aringer M, Gunther C, Anne E, Westhovens R, De Langhe E, Lenaerts J, Anic B, Baresic M, Mayer M, Uprus M, Otsa K, Yavuz S, Radominski S, Muller C, Azevedo V, Popa S, Zenone T, Stebbings S, Highton J, Mathieu A, Vacca A, Stamp L, Chapman P, O'Donnell J, Solanki K, Doube A, Veale D, O'Rourke M, Loyo E, Li M, Rosato E, Amoroso A, Gigante A, Oksel F, Yargucu F, Tanaseanu C, Popescu M, Dumitrascu A, Tiglea I, Foti R, Visalli E, Benenati A, Amato G, Ancuta C, Chirieac R, Villiger P, Adler S, Dan D, Lefebvre P, Rubio S, Exposito M, Sibilia J, Chatelus E, Gottenberg J, Chifflot H, Litinsky I, Del Galdo F, Venalis A, Saketkoo L, Lasky J, Kerzberg E, Montoya F, Cosentino V, Limonta M, Brucato A, Lupi E, Spertini F, Ribi C, Buss G, Martin T, Guffroy A, Poindron V, Chung L, Schmeiser T, Zebryk P, Riso N, Riemekasten G, Rezus E, Puttini P, and EUSTAR Collaborators

Abstract

Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Research group database. Methods Inclusion criteria were diagnosis of diffuse SSc and follow-up over 12 +/- 3 months. Disease worsening/organ progression was fulfilled if any of the following events occurred: new renal crisis; decrease of lung or heart function; new echocardiography-suspected pulmonary hypertension or death. In total, 42 clinical parameters were chosen as predictors for the analysis by using (1) imputation of missing data on the basis of multivariate imputation and (2) least absolute shrinkage and selection operator regression. Results Of 1451 patients meeting the inclusion criteria, 706 had complete data on outcome parameters and were included in the analysis. Of the 42 outcome predictors, eight remained in the final regression model. There was substantial evidence for a strong association between disease progression and age, active digital ulcer (DU), lung fibrosis, muscle weakness and elevated C-reactive protein (CRP) level. Active DU, CRP elevation, lung fibrosis and muscle weakness were also associated with a significantly shorter time to disease progression. A bootstrap validation step with 10 000 repetitions successfully validated the model. Conclusions The use of the predictive factors presented here could enable cohort enrichment with patients at risk for overall disease worsening in SSc clinical trials.

Published
2019

16. Topography and neighborhood crowding can interact to shape species growth and distribution in a diverse Amazonian forest

Author

Fortunel, Claire, Lasky, J. R., Uriarte, M., Valencia, R., Wright, S. J., Garwood, N. C., and Kraft, N. J. B.

Subjects
tropical forests, community dynamics, growth model, species coexistence, spatial interactions, functional traits, topographic gradients
Abstract

Abiotic constraints and biotic interactions act simultaneously to shape communities. However, these community assembly mechanisms are often studied independently, which can limit understanding of how they interact to affect species dynamics and distributions. We develop a hierarchical Bayesian neighborhood modeling approach to quantify the simultaneous effects of topography and crowding by neighbors on the growth of 124,704 individual stems 1cm DBH for 1,047 tropical tree species in a 25-ha mapped rainforest plot in Amazonian Ecuador. We build multi-level regression models to evaluate how four key functional traits (specific leaf area, maximum tree size, wood specific gravity and seed mass) mediate tree growth response to topography and neighborhood crowding. Tree growth is faster in valleys than on ridges and is reduced by neighborhood crowding. Topography and crowding interact to influence tree growth in similar to 10% of the species. Specific leaf area, maximum tree size and seed mass are associated with growth responses to topography, but not with responses to neighborhood crowding or with the interaction between topography and crowding. In sum, our study reveals that topography and neighborhood crowding each influence tree growth in tropical forests, but act largely independently in shaping species distributions. While traits were associated with species response to topography, their role in species response to neighborhood crowding was less clear, which suggests that trait effects on neighborhood dynamics may depend on the direction (negative/positive) and degree of symmetry of biotic interactions. Our study emphasizes the importance of simultaneously assessing the individual and interactive role of multiple mechanisms in shaping species dynamics in high diversity tropical systems.

Published
2018

19. Gene Set Enrichment Analysis Identifies a Potential Link Between Smoking and Upregulation of Olfactory Receptor and Cytokine Enrichment Pathways

Author

Schaufler, C., primary, Lasky, J., additional, Lim, B., additional, Suzuki, Y., additional, Mallem, D., additional, Oyster, M., additional, Lederer, D.J., additional, Meyer, K., additional, Bermudez, C.A., additional, Tobias, J., additional, Van Deerlin, V.M., additional, Olthoff, K., additional, Shaked, A., additional, Diamond, J.M., additional, Cantu, E., additional, and Christie, J.D., additional

Published
2017
Full Text
View/download PDF

21. Transient boron diffusion in ion-implanted crystalline and amorphous silicon.

Author

Sedgwick, T. O., Michel, A. E., Deline, V. R., Cohen, S. A., and Lasky, J. B.

Subjects
BORON, ION implantation, ANNEALING of crystals, SILICON, AMORPHOUS semiconductors
Abstract

Presents a study which compared boron diffusion in ion-implanted and annealed single-crystal and amorphized silicon. Experimental details; Results; Discussion.

Published
1988
Full Text
View/download PDF

24. The database of the PREDICTS (Projecting Responses of Ecological Diversity In Changing Terrestrial Systems) project

Author

Hudson, L., Newbold, T., Contu, S., Hill, S., Lysenko, I., De Palma, A., Phillips, H., Alhusseini, T., Bedford, F., Bennett, D., Booth, H., Burton, V., Chng, C., Choimes, A., Correia, D., Day, J., Echeverria-Londono, S., Emerson, S., Gao, D., Garon, M., Harrison, M., Ingram, D., Jung, M., Kemp, V., Kirkpatrick, L., Martin, C., Pan, Y., Pask-Hale, G., Pynegar, E., Robinson, A., Sanchez-Ortiz, K., Senior, R., Simmons, B., White, H., Zhang, H., Aben, J., Abrahamczyk, S., Adum, G., Aguilar-Barquero, V., Aizen, M., Albertos, B., Alcala, E., del Mar Alguacil, M., Alignier, A., Ancrenaz, M., Andersen, A., Arbelaez-Cortes, E., Armbrecht, I., Arroyo-Rodriguez, V., Aumann, T., Axmacher, J., Azhar, B., Azpiroz, A., Baeten, L., Bakayoko, A., Baldi, A., Banks, J., Baral, S., Barlow, J., Barratt, B., Barrico, L., Bartolommei, P., Barton, D., Basset, Y., Batary, P., Bates, A., Baur, B., Bayne, E., Beja, P., Benedick, S., Berg, A., Bernard, H., Berry, N., Bhatt, D., Bicknell, J., Bihn, J., Blake, R., Bobo, K., Bocon, R., Boekhout, T., Bohning-Gaese, K., Bonham, K., Borges, P., Borges, S., Boutin, C., Bouyer, J., Bragagnolo, C., Brandt, J., Brearley, F., Brito, I., Bros, V., Brunet, J., Buczkowski, G., Buddle, C., Bugter, R., Buscardo, E., Buse, J., Cabra-Garcia, J., Caceres, N., Cagle, N., Calvino-Cancela, M., Cameron, S., Cancello, E., Caparros, R., Cardoso, P., Carpenter, D., Carrijo, T., Carvalho, A., Cassano, C., Castro, H., Castro-Luna, A., Cerda, R., Cerezo, A., Chapman, K., Chauvat, M., Christensen, M., Clarke, F., Cleary, D., Colombo, G., Connop, S., Craig, M., Cruz-Lopez, L., Cunningham, S., D'Aniello, B., D'Cruze, N., da Silva, P., Dallimer, M., Danquah, E., Darvill, B., Dauber, J., Davis, A., Dawson, J., de Sassi, C., de Thoisy, B., Deheuvels, O., Dejean, A., Devineau, J., Diekoetter, T., Dolia, J., Dominguez, E., Dominguez-Haydar, Y., Dorn, S., Draper, I., Dreber, N., Dumont, B., Dures, S., Dynesius, M., Edenius, L., Eggleton, P., Eigenbrod, F., Elek, Z., Entling, M., Esler, K., De Lima, R., Faruk, A., Farwig, N., Fayle, T., Felicioli, A., Felton, A., Fensham, R., Fernandez, I., Ferreira, C., Ficetola, G., Fiera, C., Filgueiras, B., Firincioglu, H., Flaspohler, D., Floren, A., Fonte, S., Fournier, A., Fowler, R., Franzen, M., Fraser, L., Fredriksson, G., Freire-, G., Frizzo, T., Fukuda, D., Furlani, D., Gaigher, R., Ganzhorn, J., Garcia, K., Garcia-R, J., Garden, J., Garilleti, R., Ge, B., Gendreau-Berthiaume, B., Gerard, P., Gheler-Costa, C., Gilbert, B., Giordani, P., Giordano, S., Golodets, C., Gomes, L., Gould, R., Goulson, D., Gove, Aaron, Granjon, L., Grass, I., Gray, C., Grogan, J., Gu, W., Guardiola, M., Gunawardene, Nihara, Gutierrez, A., Gutierrez-Lamus, D., Haarmeyer, D., Hanley, M., Hanson, T., Hashim, N., Hassan, S., Hatfield, R., Hawes, J., Hayward, M., Hebert, C., Helden, A., Henden, J., Henschel, P., Hernandez, L., Herrera, J., Herrmann, F., Herzog, F., Higuera-Diaz, D., Hilje, B., Hofer, H., Hoffmann, A., Horgan, F., Hornung, E., Horvath, R., Hylander, K., Isaacs-Cubides, P., Ishida, H., Ishitani, M., Jacobs, C., Jaramillo, V., Jauker, B., Jimenez Hernandez, F., Johnson, M., Jolli, V., Jonsell, M., Juliani, S., Jung, T., Kapoor, V., Kappes, H., Kati, V., Katovai, E., Kellner, K., Kessler, M., Kirby, K., Kittle, A., Knight, M., Knop, E., Kohler, F., Koivula, M., Kolb, A., Kone, M., Koroesi, A., Krauss, J., Kumar, A., Kumar, R., Kurz, D., Kutt, A., Lachat, T., Lantschner, V., Lara, F., Lasky, J., Latta, S., Laurance, W., Lavelle, P., Le Feon, V., LeBuhn, G., Legare, J., Lehouck, V., Lencinas, M., Lentini, P., Letcher, S., Li, Q., Litchwark, S., Littlewood, N., Liu, Y., Lo-Man-Hung, N., Lopez-Quintero, C., Louhaichi, M., Lovei, G., Lucas-Borja, M., Luja, V., Luskin, M., MacSwiney G, M., Maeto, K., Magura, T., Mallari, N., Malone, L., Malonza, P., Malumbres-Olarte, J., Mandujano, S., Maren, I., Marin-Spiotta, E., Marsh, C., Marshall, E., Martinez, E., Pastur, G., Mateos, D., Mayfield, M., Mazimpaka, V., McCarthy, J., McCarthy, K., McFrederick, Q., McNamara, S., Medina, N., Medina, R., Mena, J., Mico, E., Mikusinski, G., Milder, J., Miller, J., Miranda-Esquivel, D., Moir, M., Morales, C., Muchane, M., Mudri-Stojnic, S., Munira, A., Muonz-Alonso, A., Munyekenye, B., Naidoo, R., Naithani, A., Nakagawa, M., Nakamura, A., Nakashima, Y., Naoe, S., Nates-Parra, G., Gutierrez, D., Navarro-Iriarte, L., Ndang'ang'a, P., Neuschulz, E., Ngai, J., Nicolas, V., Nilsson, S., Noreika, N., Norfolk, O., Noriega, J., Norton, D., Noeske, N., Nowakowski, A., Numa, C., O'Dea, N., O'Farrell, P., Oduro, W., Oertli, S., Ofori-Boateng, C., Oke, C., Oostra, V., Osgathorpe, L., Eduardo Otavo, S., Page, N., Paritsis, J., Parra-H, A., Parry, L., Pe'er, G., Pearman, P., Pelegrin, N., Pelissier, R., Peres, C., Peri, P., Persson, A., Petanidou, T., Peters, M., Pethiyagoda, R., Phalan, B., Philips, T., Pillsbury, F., Pincheira-Ulbrich, J., Pineda, E., Pino, J., Pizarro-Araya, J., Plumptre, A., Poggio, S., Politi, N., Pons, P., Poveda, K., Power, E., Presley, S., Proenca, V., Quaranta, M., Quintero, C., Rader, R., Ramesh, B., Ramirez-Pinilla, M., Ranganathan, J., Rasmussen, C., Redpath-Downing, N., Reid, J., Reis, Y., Rey Benayas, J., Carlos Rey-Velasco, J., Reynolds, C., Ribeiro, D., Richards, M., Richardson, B., Richardson, M., Macip Rios, R., Robinson, R., Robles, C., Roembke, J., Romero-Duque, L., Ros, M., Rosselli, L., Rossiter, S., Roth, D., Roulston, T., Rousseau, L., Rubio, A., Ruel, J., Sadler, J., Safian, S., Saldana-Vazquez, R., Sam, K., Samnegard, U., Santana, J., Santos, X., Savage, J., Schellhorn, N., Schilthuizen, M., Schmiedel, U., Schmitt, C., Schon, N., Schuepp, C., Schumann, K., Schweiger, O., Scott, D., Scott, K., Sedlock, J., Seefeldt, S., Shahabuddin, G., Shannon, G., Sheil, D., Sheldon, F., Shochat, E., Siebert, S., Silva, F., Simonetti, J., Slade, E., Smith, J., Smith-Pardo, A., Sodhi, N., Somarriba, E., Sosa, R., Soto Quiroga, G., St-Laurent, M., Starzomski, B., Stefanescu, C., Steffan-Dewenter, I., Stouffer, P., Stout, J., Strauch, A., Struebig, M., Su, Z., Suarez-Rubio, M., Sugiura, S., Summerville, K., Sung, Y., Sutrisno, H., Svenning, J., Teder, T., Threlfall, C., Tiitsaar, A., Todd, J., Tonietto, R., Torre, I., Tothmeresz, B., Tscharntke, T., Turner, E., Tylianakis, J., Uehara-Prado, M., Urbina-Cardona, N., Vallan, D., Vanbergen, A., Vasconcelos, H., Vassilev, K., Verboven, H., Verdasca, M., Verdu, J., Vergara, C., Vergara, P., Verhulst, J., Virgilio, M., Van Vu, L., Waite, E., Walker, T., Wang, H., Wang, Y., Watling, J., Weller, B., Wells, K., Westphal, C., Wiafe, E., Williams, C., Willig, M., Woinarski, J., Wolf, J., Wolters, V., Woodcock, B., Wu, J., Wunderle, J., Yamaura, Y., Yoshikura, S., Yu, D., Zaitsev, A., Zeidler, J., Zou, F., Collen, B., Ewers, R., Mace, G., Purves, D., Scharlemann, J., Purvis, A., Hudson, L., Newbold, T., Contu, S., Hill, S., Lysenko, I., De Palma, A., Phillips, H., Alhusseini, T., Bedford, F., Bennett, D., Booth, H., Burton, V., Chng, C., Choimes, A., Correia, D., Day, J., Echeverria-Londono, S., Emerson, S., Gao, D., Garon, M., Harrison, M., Ingram, D., Jung, M., Kemp, V., Kirkpatrick, L., Martin, C., Pan, Y., Pask-Hale, G., Pynegar, E., Robinson, A., Sanchez-Ortiz, K., Senior, R., Simmons, B., White, H., Zhang, H., Aben, J., Abrahamczyk, S., Adum, G., Aguilar-Barquero, V., Aizen, M., Albertos, B., Alcala, E., del Mar Alguacil, M., Alignier, A., Ancrenaz, M., Andersen, A., Arbelaez-Cortes, E., Armbrecht, I., Arroyo-Rodriguez, V., Aumann, T., Axmacher, J., Azhar, B., Azpiroz, A., Baeten, L., Bakayoko, A., Baldi, A., Banks, J., Baral, S., Barlow, J., Barratt, B., Barrico, L., Bartolommei, P., Barton, D., Basset, Y., Batary, P., Bates, A., Baur, B., Bayne, E., Beja, P., Benedick, S., Berg, A., Bernard, H., Berry, N., Bhatt, D., Bicknell, J., Bihn, J., Blake, R., Bobo, K., Bocon, R., Boekhout, T., Bohning-Gaese, K., Bonham, K., Borges, P., Borges, S., Boutin, C., Bouyer, J., Bragagnolo, C., Brandt, J., Brearley, F., Brito, I., Bros, V., Brunet, J., Buczkowski, G., Buddle, C., Bugter, R., Buscardo, E., Buse, J., Cabra-Garcia, J., Caceres, N., Cagle, N., Calvino-Cancela, M., Cameron, S., Cancello, E., Caparros, R., Cardoso, P., Carpenter, D., Carrijo, T., Carvalho, A., Cassano, C., Castro, H., Castro-Luna, A., Cerda, R., Cerezo, A., Chapman, K., Chauvat, M., Christensen, M., Clarke, F., Cleary, D., Colombo, G., Connop, S., Craig, M., Cruz-Lopez, L., Cunningham, S., D'Aniello, B., D'Cruze, N., da Silva, P., Dallimer, M., Danquah, E., Darvill, B., Dauber, J., Davis, A., Dawson, J., de Sassi, C., de Thoisy, B., Deheuvels, O., Dejean, A., Devineau, J., Diekoetter, T., Dolia, J., Dominguez, E., Dominguez-Haydar, Y., Dorn, S., Draper, I., Dreber, N., Dumont, B., Dures, S., Dynesius, M., Edenius, L., Eggleton, P., Eigenbrod, F., Elek, Z., Entling, M., Esler, K., De Lima, R., Faruk, A., Farwig, N., Fayle, T., Felicioli, A., Felton, A., Fensham, R., Fernandez, I., Ferreira, C., Ficetola, G., Fiera, C., Filgueiras, B., Firincioglu, H., Flaspohler, D., Floren, A., Fonte, S., Fournier, A., Fowler, R., Franzen, M., Fraser, L., Fredriksson, G., Freire-, G., Frizzo, T., Fukuda, D., Furlani, D., Gaigher, R., Ganzhorn, J., Garcia, K., Garcia-R, J., Garden, J., Garilleti, R., Ge, B., Gendreau-Berthiaume, B., Gerard, P., Gheler-Costa, C., Gilbert, B., Giordani, P., Giordano, S., Golodets, C., Gomes, L., Gould, R., Goulson, D., Gove, Aaron, Granjon, L., Grass, I., Gray, C., Grogan, J., Gu, W., Guardiola, M., Gunawardene, Nihara, Gutierrez, A., Gutierrez-Lamus, D., Haarmeyer, D., Hanley, M., Hanson, T., Hashim, N., Hassan, S., Hatfield, R., Hawes, J., Hayward, M., Hebert, C., Helden, A., Henden, J., Henschel, P., Hernandez, L., Herrera, J., Herrmann, F., Herzog, F., Higuera-Diaz, D., Hilje, B., Hofer, H., Hoffmann, A., Horgan, F., Hornung, E., Horvath, R., Hylander, K., Isaacs-Cubides, P., Ishida, H., Ishitani, M., Jacobs, C., Jaramillo, V., Jauker, B., Jimenez Hernandez, F., Johnson, M., Jolli, V., Jonsell, M., Juliani, S., Jung, T., Kapoor, V., Kappes, H., Kati, V., Katovai, E., Kellner, K., Kessler, M., Kirby, K., Kittle, A., Knight, M., Knop, E., Kohler, F., Koivula, M., Kolb, A., Kone, M., Koroesi, A., Krauss, J., Kumar, A., Kumar, R., Kurz, D., Kutt, A., Lachat, T., Lantschner, V., Lara, F., Lasky, J., Latta, S., Laurance, W., Lavelle, P., Le Feon, V., LeBuhn, G., Legare, J., Lehouck, V., Lencinas, M., Lentini, P., Letcher, S., Li, Q., Litchwark, S., Littlewood, N., Liu, Y., Lo-Man-Hung, N., Lopez-Quintero, C., Louhaichi, M., Lovei, G., Lucas-Borja, M., Luja, V., Luskin, M., MacSwiney G, M., Maeto, K., Magura, T., Mallari, N., Malone, L., Malonza, P., Malumbres-Olarte, J., Mandujano, S., Maren, I., Marin-Spiotta, E., Marsh, C., Marshall, E., Martinez, E., Pastur, G., Mateos, D., Mayfield, M., Mazimpaka, V., McCarthy, J., McCarthy, K., McFrederick, Q., McNamara, S., Medina, N., Medina, R., Mena, J., Mico, E., Mikusinski, G., Milder, J., Miller, J., Miranda-Esquivel, D., Moir, M., Morales, C., Muchane, M., Mudri-Stojnic, S., Munira, A., Muonz-Alonso, A., Munyekenye, B., Naidoo, R., Naithani, A., Nakagawa, M., Nakamura, A., Nakashima, Y., Naoe, S., Nates-Parra, G., Gutierrez, D., Navarro-Iriarte, L., Ndang'ang'a, P., Neuschulz, E., Ngai, J., Nicolas, V., Nilsson, S., Noreika, N., Norfolk, O., Noriega, J., Norton, D., Noeske, N., Nowakowski, A., Numa, C., O'Dea, N., O'Farrell, P., Oduro, W., Oertli, S., Ofori-Boateng, C., Oke, C., Oostra, V., Osgathorpe, L., Eduardo Otavo, S., Page, N., Paritsis, J., Parra-H, A., Parry, L., Pe'er, G., Pearman, P., Pelegrin, N., Pelissier, R., Peres, C., Peri, P., Persson, A., Petanidou, T., Peters, M., Pethiyagoda, R., Phalan, B., Philips, T., Pillsbury, F., Pincheira-Ulbrich, J., Pineda, E., Pino, J., Pizarro-Araya, J., Plumptre, A., Poggio, S., Politi, N., Pons, P., Poveda, K., Power, E., Presley, S., Proenca, V., Quaranta, M., Quintero, C., Rader, R., Ramesh, B., Ramirez-Pinilla, M., Ranganathan, J., Rasmussen, C., Redpath-Downing, N., Reid, J., Reis, Y., Rey Benayas, J., Carlos Rey-Velasco, J., Reynolds, C., Ribeiro, D., Richards, M., Richardson, B., Richardson, M., Macip Rios, R., Robinson, R., Robles, C., Roembke, J., Romero-Duque, L., Ros, M., Rosselli, L., Rossiter, S., Roth, D., Roulston, T., Rousseau, L., Rubio, A., Ruel, J., Sadler, J., Safian, S., Saldana-Vazquez, R., Sam, K., Samnegard, U., Santana, J., Santos, X., Savage, J., Schellhorn, N., Schilthuizen, M., Schmiedel, U., Schmitt, C., Schon, N., Schuepp, C., Schumann, K., Schweiger, O., Scott, D., Scott, K., Sedlock, J., Seefeldt, S., Shahabuddin, G., Shannon, G., Sheil, D., Sheldon, F., Shochat, E., Siebert, S., Silva, F., Simonetti, J., Slade, E., Smith, J., Smith-Pardo, A., Sodhi, N., Somarriba, E., Sosa, R., Soto Quiroga, G., St-Laurent, M., Starzomski, B., Stefanescu, C., Steffan-Dewenter, I., Stouffer, P., Stout, J., Strauch, A., Struebig, M., Su, Z., Suarez-Rubio, M., Sugiura, S., Summerville, K., Sung, Y., Sutrisno, H., Svenning, J., Teder, T., Threlfall, C., Tiitsaar, A., Todd, J., Tonietto, R., Torre, I., Tothmeresz, B., Tscharntke, T., Turner, E., Tylianakis, J., Uehara-Prado, M., Urbina-Cardona, N., Vallan, D., Vanbergen, A., Vasconcelos, H., Vassilev, K., Verboven, H., Verdasca, M., Verdu, J., Vergara, C., Vergara, P., Verhulst, J., Virgilio, M., Van Vu, L., Waite, E., Walker, T., Wang, H., Wang, Y., Watling, J., Weller, B., Wells, K., Westphal, C., Wiafe, E., Williams, C., Willig, M., Woinarski, J., Wolf, J., Wolters, V., Woodcock, B., Wu, J., Wunderle, J., Yamaura, Y., Yoshikura, S., Yu, D., Zaitsev, A., Zeidler, J., Zou, F., Collen, B., Ewers, R., Mace, G., Purves, D., Scharlemann, J., and Purvis, A.

Abstract

The PREDICTS project—Projecting Responses of Ecological Diversity In Changing Terrestrial Systems (www.predicts.org.uk)—has collated from published studies a large, reasonably representative database of comparable samples of biodiversity from multiple sites that differ in the nature or intensity of human impacts relating to land use. We have used this evidence base to develop global and regional statistical models of how local biodiversity responds to these measures. We describe and make freely available this 2016 release of the database, containing more than 3.2 million records sampled at over 26,000 locations and representing over 47,000 species. We outline how the database can help in answering a range of questions in ecology and conservation biology. To our knowledge, this is the largest and most geographically and taxonomically representative database of spatial comparisons of biodiversity that has been collated to date; it will be useful to researchers and international efforts wishing to model and understand the global status of biodiversity.

Published
2017

25. Redefining Primary Graft Dysfunction after Lung Transplantation

Author

Cantu, E., primary, Diamond, J., additional, Nellen, J., additional, Beduhn, B., additional, Suzuki, Y., additional, Borders, C., additional, Lasky, J., additional, Schaufler, C., additional, Shah, R., additional, Porteous, M., additional, Lederer, D.J., additional, Kawut, S.M., additional, Arcasoy, S., additional, Palmer, S.M., additional, Snyder, L., additional, Hartwig, M.G., additional, Lama, V.N., additional, Crespo, M., additional, Wille, K., additional, Orens, J., additional, Shah, P.D., additional, Weinacker, A., additional, Ware, L.B., additional, Bellamy, S.L., additional, and Christie, J.D., additional

Published
2016
Full Text
View/download PDF

27. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Author

Luca, Richeldi, du Bois, Roland M., Ganesh, Raghu, Arata, Azuma, Brown, Kevin K., Ulrich, Costabel, Vincent, Cottin, Flaherty, Kevin R., Hansell, David M., Yoshikazu, Inoue, Dong Soon Kim, Martin, Kolb, Nicholson, Andrew G., Noble, Paul W., Moisés, Selman, Hiroyuki, Taniguchi, Michèle, Brun, Florence Le Maulf, Mannaïg, Girard, Susanne, Stowasser, Rozsa Schlenker Herceg, Bernd, Disse, Collard, Harold R., Corte, T, Davies, H, Glaspole, I, Mulder, J, Veitch, E, De Vuyst, P, Liistro, G, Sibille, Y, Vincken, W, Wuyts, W, Fell, C, Hernandez, P, Kolb, M, Undurraga, A, Bai, C, Chen, P, Gao, Z, Kang, J, Li, H, Li, Z, Wan, H, Wang, H, Wen, F, Xiao, Q, Xu, Z, Zhang, W, Zheng, X, Zhu, H, Pauk, N, Reiterer, P, Vasakova, M, Hodgson, U, Bourdin, A, Cadranel, J, Camus, P, Chanez, P, Cottin, V, Crestani, B, Israel Biet, D, Jouneau, S, Lebargy, F, Marquette, C, Prévot, G, Valeyre, D, Wallaert, B, Bonnet, R, Costabel, U, Gläser, S, Grohé, C, Guenther, A, Hammerl, P, Höffken, G, Karagiannidis, C, Kirschner, J, Kirsten, A, Korn, S, Kreuter, M, Müller Quernheim, J, Neurohr, C, Pfeifer, M, Schönfeld, N, Wiewrodt, R, Antoniou, K, Daniil, Z, Diamantea, F, Koulouris, N, Mathioudakis, G, Ghosal, A, Kadappa Shivappa, S, Kawedia, M, Khatavkar, P, Kumar, A, Mehta, P, Singh, V, Srikanth, K, Thakker, H, Udwadia, Z, Egan, J, Fink, G, Kramer, M, Yigla, M, Agostini, Carlo, De Benedetto, F, Harari, S, Luppi, F, Paggiaro, P, Tavanti, L, Pesci, A, Poletti, V, Rottoli, P, Saltini, C, Sanduzzi Zamparelli, A, Vancheri, C, Bando, M, Hasegawa, Y, Hashimoto, K, Homma, S, Inase, N, Inoue, Y, Arai, T, Izumi, S, Kawamura, T, Kishi, K, Kondo, Y, Kuwano, K, Miura, Y, Nishioka, Y, Nishiyama, O, Ogura, T, Ohkouchi, S, Saito, T, Setoguchi, Y, Shindoh, J, Taguchi, Y, Tanakadate, M, Tomii, K, Sugita, Y, Yamaguchi, T, Yoshimori, K, Jeong, S, Kim, D, Kim, Y, Park, C, Song, J, Uh, S, Selman, M, Bresser, P, Grutters, J, Wijsenbeek, M, Arrobas, A, Cardoso, J, Costa, R, Morais, A, Neves, S, Serrado, M, Ilkovick, M, Vizel, A, Alfageme Michavila, I, Ancochea, J, Castillo Villegas, D, Molina Molina, M, Morell, F, Xaubet, A, Aktogu Ozkan, S, Kayacan, O, Ongen, G, Mogulkoc, N, Tuncay, E, Beirne, P, Bettinson, H, Burge, P, Dempsey, O, Maher, T, Millar, A, Spencer, L, Thickett, D, Alvarez, J, Andrews, C, Bajwa, O, Baker, A, Baughman, R, Belperio, J, Bradley, J, Collard, H, Cordova, F, Daniels, C, de Andrade, J, Dushay, K, Enelow, R, Ettinger, N, Gibson, K, Gotfried, M, Hajari Case, A, Hotchkin, D, Huggins, J, Kaye, M, Kershaw, C, Kureishy, S, Lancaster, L, Lederer, D, Mageto, Y, Masson, J, Meyer, K, Mohabir, P, Morrison, L, Nathan, S, Noth, I, Oelberg, D, Rahaghi, F, Riley, D, Rizzo, A, Rossman, M, Ruzi, J, Sachs, P, Schaumberg, T, Scholand, M, Schroeder, C, Seifer, F, Shea, J, Sinkowitz, D, Tabak, J, Taylor, J, Thompson, J, Thurm, C, Tita, J, Wencel, M, Westerman, J, Lasky, J, Demedts, M, Casteels, M, Loddenkemper, R, Michaelis, J, Roman, J, Tino, G, Luisetti, M., and Clinical sciences

Subjects
Male, medicine.medical_specialty, Vital capacity, Indoles, Exacerbation, Aged, Disease Progression, Double-Blind Method, Enzyme Inhibitors, Female, Humans, Idiopathic Pulmonary Fibrosis, Middle Aged, Protein Kinase Inhibitors, Protein-Tyrosine Kinases, Quality of Life, Treatment Outcome, Vital Capacity, Settore MED/10 - Malattie dell'Apparato Respiratorio, Medizin, Placebo, Gastroenterology, FEV1/FVC ratio, Idiopathic pulmonary fibrosis, chemistry.chemical_compound, Internal medicine, medicine, business.industry, Medicine (all), Hazard ratio, General Medicine, Pirfenidone, medicine.disease, Surgery, chemistry, Nintedanib, business, medicine.drug
Abstract

Background Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis. Methods We conducted two replicate 52-week, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis. The primary end point was the annual rate of decline in forced vital capacity (FVC). Key secondary end points were the time to the first acute exacerbation and the change from baseline in the total score on the St. George’s Respiratory Questionnaire, both assessed over a 52-week period. Results A total of 1066 patients were randomly assigned in a 3:2 ratio to receive nintedanib or placebo. The adjusted annual rate of change in FVC was −114.7 ml with nintedanib versus −239.9 ml with placebo (difference, 125.3 ml; 95% confidence interval [CI], 77.7 to 172.8; P

Published
2014

28. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Author

King TE Jr, Albera, C, Bradford, Wz, Costabel, U, Hormel, P, Lancaster, L, Noble, Pw, Sahn, Sa, Szwarcberg, J, Thomeer, M, Valeyre, D, du Bois RM, INSPIRE Study Group, Agostini, Carlo, Allen, J, Anzueto, A, Behr, J, Bonnet, R, Buhl, R, Burge, S, Chan, A, Chan, C, Chanez, P, Chapman, J, Cordier, J, Covelli, H, Crimi, N, de Andrade, J, Delaval, P, Dromer, C, Egan, J, Enelow, R, Ettinger, N, Flaherty, K, Floreani, A, Frankel, S, Frost, A, Gibson, K, Glassberg, M, Gottfried, M, Harari, S, Helmersen, D, Hollingsworth, H, Horton, M, Jennings, J, Kallay, M, Lasky, J, Lee, A, Leonard, C, Lorch, D, Lynch, J, Mageto, Y, Mette, S, Millar, A, Morell Brotad, F, Müller Quernheim, J, Nathan, S, Noth, I, Padilla, M, Poletti, V, Raghu, G, Richeldi, L, Robbins, M, Rolf, J, Roman, J, Rosen, G, Rottoli, P, Saltini, C, Schaberg, T, Schaumberg, T, Scholand, M, Schönfeld, N, Sharma, S, Simonelli, P, Steele, M, Sussman, R, Tino, G, Vogelmeier, C, Wallaert, B, Wells, A, Wencel, M, Wesselius, L, Whelan, T, Wilcox, P, Wolters, P, Xaubet, A, and Zisman, D.

Subjects
Male, medicine.medical_specialty, Settore MED/10 - Malattie dell'Apparato Respiratorio, Injections, Subcutaneous, Vital Capacity, Placebo-controlled study, Kaplan-Meier Estimate, Placebo, Severity of Illness Index, Drug Administration Schedule, Pulmonary function testing, Injections, Idiopathic pulmonary fibrosis, Interferon-gamma, Double-Blind Method, Internal medicine, Pulmonary fibrosis, medicine, Humans, Aged, Analysis of Variance, Disease Progression, Europe, Exercise Test, Female, Idiopathic Pulmonary Fibrosis, North America, Proportional Hazards Models, Pulmonary Diffusing Capacity, Recombinant Proteins, Survival Rate, Treatment Failure, Medicine (all), Survival rate, business.industry, Subcutaneous, Hazard ratio, General Medicine, Interim analysis, medicine.disease, Surgery, business
Abstract

Summary Background Idiopathic pulmonary fibrosis is a fatal disease for which no effective treatment exists. We assessed whether treatment with interferon gamma-1b improved survival compared with placebo in patients with idiopathic pulmonary fibrosis and mild-to-moderate impairment of pulmonary function. Methods 826 patients with idiopathic pulmonary fibrosis were enrolled from 81 centres in seven European countries, the USA, and Canada. Patients were randomly assigned (double-blind) in a 2:1 ratio to receive 200 μg interferon gamma-1b (n=551) or equivalent placebo (n=275) subcutaneously, three times per week. Eligible patients were aged 40–79 years, had been diagnosed in the past 48 months, had a forced vital capacity of 55–90% of the predicted value, and a haemoglobin-corrected carbon monoxide diffusing capacity of 35–90% of the predicted value. The primary endpoint was overall survival time from randomisation measured at the second interim analysis, when the proportion of deaths had reached 75% of those expected by the study conclusion. This study is registered with ClinicalTrials.gov, number NCT00075998. Findings At the second interim analysis, the hazard ratio for mortality in patients on interferon gamma-1b showed absence of minimum benefit compared with placebo (1·15, 95% CI 0·77–1·71, p=0·497), and indicated that the study should be stopped. After a median duration of 64 weeks (IQR 41–84) on treatment, 80 (15%) patients on interferon gamma-1b and 35 (13%) on placebo had died. Almost all patients reported at least one adverse event, and more patients on interferon gamma-1b group had constitutional signs and symptoms (influenza-like illness, fatigue, fever, and chills) than did those on placebo. Occurrence of serious adverse events (eg, pneumonia, respiratory failure) was similar for both treatment groups. Treatment adherence was good and few patients discontinued treatment prematurely in either group. Interpretation We cannot recommend treatment with interferon gamma-1b since the drug did not improve survival for patients with idiopathic pulmonary fibrosis, which refutes previous findings from subgroup analyses of survival in studies of patients with mild-to-moderate physiological impairment of pulmonary function. Funding InterMune.

Published
2009

32. HIGH GRADE GLIOMAS AND DIPG

Author

Classen, C. F., primary, William, D., additional, Linnebacher, M., additional, Farhod, A., additional, Kedr, W., additional, Elsabe, B., additional, Fadel, S., additional, Van Gool, S., additional, De Vleeschouwer, S., additional, Koks, C., additional, Garg, A., additional, Ehrhardt, M., additional, Riva, M., additional, Agostinis, P., additional, Graf, N., additional, Yao, T.-W., additional, Yoshida, Y., additional, Zhang, J., additional, Ozawa, T., additional, James, D., additional, Nicolaides, T., additional, Kebudi, R., additional, Cakir, F. B., additional, Gorgun, O., additional, Agaoglu, F. Y., additional, Darendeliler, E., additional, Al-Kofide, A., additional, Al-Shail, E., additional, Khafaga, Y., additional, Al-Hindi, H., additional, Dababo, M., additional, Haq, A. U., additional, Anas, M., additional, Barria, M. G., additional, Siddiqui, K., additional, Hassounah, M., additional, Ayas, M., additional, van Zanten, S. V., additional, Jansen, M., additional, van Vuurden, D., additional, Huisman, M., additional, Vugts, D., additional, Hoekstra, O., additional, van Dongen, G., additional, Kaspers, G., additional, Cockle, J., additional, Ilett, E., additional, Scott, K., additional, Bruning-Richardson, A., additional, Picton, S., additional, Short, S., additional, Melcher, A., additional, Benesch, M., additional, Warmuth-Metz, M., additional, von Bueren, A. O., additional, Hoffmann, M., additional, Pietsch, T., additional, Kortmann, R.-D., additional, Eyrich, M., additional, Rutkowski, S., additional, Fruhwald, M. C., additional, Faber, J., additional, Kramm, C., additional, Porkholm, M., additional, Valanne, L., additional, Lonnqvist, T., additional, Holm, S., additional, Lannering, B., additional, Riikonen, P., additional, Wojcik, D., additional, Sehested, A., additional, Clausen, N., additional, Harila-Saari, A., additional, Schomerus, E., additional, Thorarinsdottir, H. K., additional, Lahteenmaki, P., additional, Arola, M., additional, Thomassen, H., additional, Saarinen-Pihkala, U. M., additional, Kivivuori, S.-M., additional, Buczkowicz, P., additional, Hoeman, C., additional, Rakopoulos, P., additional, Pajovic, S., additional, Morrison, A., additional, Bouffet, E., additional, Bartels, U., additional, Becher, O., additional, Hawkins, C., additional, Gould, T. W. A., additional, Rahman, C. V., additional, Smith, S. J., additional, Barrett, D. A., additional, Shakesheff, K. M., additional, Grundy, R. G., additional, Rahman, R., additional, Barua, N., additional, Cronin, D., additional, Gill, S., additional, Lowisl, S., additional, Hochart, A., additional, Maurage, C.-A., additional, Rocourt, N., additional, Vinchon, M., additional, Kerdraon, O., additional, Escande, F., additional, Grill, J., additional, Pick, V. K., additional, Leblond, P., additional, Burzynski, G., additional, Janicki, T., additional, Burzynski, S., additional, Marszalek, A., additional, Ramani, N., additional, Zaky, W., additional, Kannan, G., additional, Morani, A., additional, Sandberg, D., additional, Ketonen, L., additional, Maher, O., additional, Corrales-Medina, F., additional, Meador, H., additional, Khatua, S., additional, Brassesco, M., additional, Delsin, L., additional, Roberto, G., additional, Silva, C., additional, Ana, L., additional, Rego, E., additional, Scrideli, C., additional, Umezawa, K., additional, Tone, L., additional, Kim, S. J., additional, Kim, C.-Y., additional, Kim, I.-A., additional, Han, J. H., additional, Choi, B.-S., additional, Ahn, H. S., additional, Choi, H. S., additional, Haque, F., additional, Layfield, R., additional, Grundy, R., additional, Gandola, L., additional, Pecori, E., additional, Biassoni, V., additional, Schiavello, E., additional, Chiruzzi, C., additional, Spreafico, F., additional, Modena, P., additional, Bach, F., additional, Pignoli, E., additional, Massimino, M., additional, Drogosiewicz, M., additional, Dembowska-Baginska, B., additional, Jurkiewicz, E., additional, Filipek, I., additional, Perek-Polnik, M., additional, Swieszkowska, E., additional, Perek, D., additional, Bender, S., additional, Jones, D. T., additional, Warnatz, H.-J., additional, Hutter, B., additional, Zichner, T., additional, Gronych, J., additional, Korshunov, A., additional, Eils, R., additional, Korbel, J. O., additional, Yaspo, M.-L., additional, Lichter, P., additional, Pfister, S. M., additional, Yadavilli, S., additional, Becher, O. J., additional, Kambhampati, M., additional, Packer, R. J., additional, Nazarian, J., additional, Lechon, F. C., additional, Fowkes, L., additional, Khabra, K., additional, Martin-Retortillo, L. M., additional, Marshall, L. V., additional, Vaidya, S., additional, Koh, D.-M., additional, Leach, M. O., additional, Pearson, A. D., additional, Zacharoulis, S., additional, Schrey, D., additional, Barone, G., additional, Panditharatna, E., additional, Stampar, M., additional, Siu, A., additional, Gordish-Dressman, H., additional, Devaney, J., additional, Hwang, E. I., additional, Chung, A. H., additional, Mittapalli, R. K., additional, Elmquist, W. F., additional, Castel, D., additional, Debily, M.-A., additional, Philippe, C., additional, Truffaux, N., additional, Taylor, K., additional, Calmon, R., additional, Boddaert, N., additional, Le Dret, L., additional, Saulnier, P., additional, Lacroix, L., additional, Mackay, A., additional, Jones, C., additional, Puget, S., additional, Sainte-Rose, C., additional, Blauwblomme, T., additional, Varlet, P., additional, Entz-Werle, N., additional, Maugard, C., additional, Bougeard, G., additional, Nguyen, A., additional, Chenard, M. P., additional, Schneider, A., additional, Gaub, M. P., additional, Tsoli, M., additional, Vanniasinghe, A., additional, Luk, P., additional, Dilda, P., additional, Haber, M., additional, Hogg, P., additional, Ziegler, D., additional, Simon, S., additional, Monje, M., additional, Gurova, K., additional, Gudkov, A., additional, Zapotocky, M., additional, Churackova, M., additional, Malinova, B., additional, Zamecnik, J., additional, Kyncl, M., additional, Tichy, M., additional, Puchmajerova, A., additional, Stary, J., additional, Sumerauer, D., additional, Boult, J., additional, Vinci, M., additional, Perryman, L., additional, Box, G., additional, Jury, A., additional, Popov, S., additional, Ingram, W., additional, Eccles, S., additional, Robinson, S., additional, Emir, S., additional, Demir, H. A., additional, Bayram, C., additional, Cetindag, F., additional, Kabacam, G. B., additional, Fettah, A., additional, Li, J., additional, Jamin, Y., additional, Cummings, C., additional, Bamber, J., additional, Sinkus, R., additional, Nandhabalan, M., additional, Bjerke, L., additional, Burford, A., additional, von Bueren, A., additional, Baudis, M., additional, Clarke, P., additional, Collins, I., additional, Workman, P., additional, Olaciregui, N., additional, Mora, J., additional, Carcaboso, A., additional, Bullock, A., additional, Alonso, M., additional, de Torres, C., additional, Cruz, O., additional, Pencreach, E., additional, Moussalieh, F. M., additional, Guenot, D., additional, Namer, I., additional, Pollack, I., additional, Jakacki, R., additional, Butterfield, L., additional, Hamilton, R., additional, Panigrahy, A., additional, Potter, D., additional, Connelly, A., additional, Dibridge, S., additional, Whiteside, T., additional, Okada, H., additional, Ahsan, S., additional, Raabe, E., additional, Haffner, M., additional, Warren, K., additional, Quezado, M., additional, Ballester, L., additional, Eberhart, C., additional, Rodriguez, F., additional, Ramachandran, C., additional, Nair, S., additional, Quirrin, K.-W., additional, Khatib, Z., additional, Escalon, E., additional, Melnick, S., additional, Classen, C. F., additional, Hofmann, M., additional, Schmid, I., additional, Simon, T., additional, Maass, E., additional, Russo, A., additional, Fleischhack, G., additional, Becker, M., additional, Hauch, H., additional, Sander, A., additional, Grasso, C., additional, Berlow, N., additional, Liu, L., additional, Davis, L., additional, Huang, E., additional, Woo, P., additional, Tang, Y., additional, Ponnuswami, A., additional, Chen, S., additional, Huang, Y., additional, Hutt-Cabezas, M., additional, Dret, L., additional, Meltzer, P., additional, Mao, H., additional, Abraham, J., additional, Fouladi, M., additional, Svalina, M. N., additional, Wang, N., additional, Hulleman, E., additional, Li, X.-N., additional, Keller, C., additional, Spellman, P. T., additional, Pal, R., additional, Jansen, M. H. A., additional, Sewing, A. C. P., additional, Lagerweij, T., additional, Vuchts, D. J., additional, van Vuurden, D. G., additional, Caretti, V., additional, Wesseling, P., additional, Kaspers, G. J. L., additional, Cohen, K., additional, Pearl, M., additional, Kogiso, M., additional, Zhang, L., additional, Qi, L., additional, Lindsay, H., additional, Lin, F., additional, Berg, S., additional, Muscal, J., additional, Amayiri, N., additional, Tabori, U., additional, Campbel, B., additional, Bakry, D., additional, Aronson, M., additional, Durno, C., additional, Gallinger, S., additional, Malkin, D., additional, Qaddumi, I., additional, Musharbash, A., additional, Swaidan, M., additional, Al-Hussaini, M., additional, Shandilya, S., additional, McCully, C., additional, Murphy, R., additional, Akshintala, S., additional, Cole, D., additional, Macallister, R. P., additional, Cruz, R., additional, Widemann, B., additional, Salloum, R., additional, Smith, A., additional, Glaunert, M., additional, Ramkissoon, A., additional, Peterson, S., additional, Baker, S., additional, Chow, L., additional, Sandgren, J., additional, Pfeifer, S., additional, Popova, S., additional, Alafuzoff, I., additional, de Stahl, T. D., additional, Pietschmann, S., additional, Kerber, M. J., additional, Zwiener, I., additional, Henke, G., additional, Muller, K., additional, Sieow, N. Y.-F., additional, Hoe, R. H. M., additional, Tan, A. M., additional, Chan, M. Y., additional, Soh, S. Y., additional, Burrell, K., additional, Chornenkyy, Y., additional, Remke, M., additional, Golbourn, B., additional, Barzczyk, M., additional, Taylor, M., additional, Rutka, J., additional, Dirks, P., additional, Zadeh, G., additional, Agnihotri, S., additional, Hashizume, R., additional, Ihara, Y., additional, Andor, N., additional, Chen, X., additional, Lerner, R., additional, Huang, X., additional, Tom, M., additional, Solomon, D., additional, Mueller, S., additional, Petritsch, C., additional, Zhang, Z., additional, Gupta, N., additional, Waldman, T., additional, Dujua, A., additional, Co, J., additional, Hernandez, F., additional, Doromal, D., additional, Hegde, M., additional, Wakefield, A., additional, Brawley, V., additional, Grada, Z., additional, Byrd, T., additional, Chow, K., additional, Krebs, S., additional, Heslop, H., additional, Gottschalk, S., additional, Yvon, E., additional, Ahmed, N., additional, Cornilleau, G., additional, Paulsson, J., additional, Andreiuolo, F., additional, Guerrini-Rousseau, L., additional, Geoerger, B., additional, Vassal, G., additional, Ostman, A., additional, Parsons, D. W., additional, Trevino, L. R., additional, Gao, F., additional, Shen, X., additional, Hampton, O., additional, Kosigo, M., additional, Baxter, P. A., additional, Su, J. M., additional, Chintagumpala, M., additional, Dauser, R., additional, Adesina, A., additional, Plon, S. E., additional, Wheeler, D. A., additional, Lau, C. C., additional, Gielen, G., additional, Muehlen, A. z., additional, Kwiecien, R., additional, Wolff, J., additional, Lulla, R. R., additional, Laskowski, J., additional, Goldman, S., additional, Gopalakrishnan, V., additional, Fangusaro, J., additional, Kieran, M., additional, Fontebasso, A., additional, Papillon-Cavanagh, S., additional, Schwartzentruber, J., additional, Nikbakht, H., additional, Gerges, N., additional, Fiset, P.-O., additional, Bechet, D., additional, Faury, D., additional, De Jay, N., additional, Ramkissoon, L., additional, Corcoran, A., additional, Jones, D., additional, Sturm, D., additional, Johann, P., additional, Tomita, T., additional, Nagib, M., additional, Bendel, A., additional, Goumnerova, L., additional, Bowers, D. C., additional, Leonard, J. R., additional, Rubin, J. B., additional, Alden, T., additional, DiPatri, A., additional, Browd, S., additional, Leary, S., additional, Jallo, G., additional, Prados, M. D., additional, Banerjee, A., additional, Carret, A.-S., additional, Ellezam, B., additional, Crevier, L., additional, Klekner, A., additional, Bognar, L., additional, Hauser, P., additional, Garami, M., additional, Myseros, J., additional, Dong, Z., additional, Siegel, P. M., additional, Gump, W., additional, Ayyanar, K., additional, Ragheb, J., additional, Krieger, M., additional, Kiehna, E., additional, Robison, N., additional, Harter, D., additional, Gardner, S., additional, Handler, M., additional, Foreman, N., additional, Brahma, B., additional, MacDonald, T., additional, Malkin, H., additional, Chi, S., additional, Manley, P., additional, Bandopadhayay, P., additional, Greenspan, L., additional, Ligon, A., additional, Albrecht, S., additional, Ligon, K. L., additional, Majewski, J., additional, Jabado, N., additional, Cordero, F., additional, Halvorson, K., additional, Taylor, I., additional, Hutt, M., additional, Weingart, M., additional, Price, A., additional, Kantar, M., additional, Onen, S., additional, Kamer, S., additional, Turhan, T., additional, Kitis, O., additional, Ertan, Y., additional, Cetingul, N., additional, Anacak, Y., additional, Akalin, T., additional, Ersahin, Y., additional, Mason, G., additional, Ho, C., additional, Crozier, F., additional, Vezina, G., additional, Packer, R., additional, Hwang, E., additional, Gilheeney, S., additional, Millard, N., additional, DeBraganca, K., additional, Khakoo, Y., additional, Kramer, K., additional, Wolden, S., additional, Donzelli, M., additional, Fischer, C., additional, Petriccione, M., additional, Dunkel, I., additional, Afzal, S., additional, Fleming, A., additional, Larouche, V., additional, Zelcer, S., additional, Johnston, D. L., additional, Kostova, M., additional, Mpofu, C., additional, Decarie, J.-C., additional, Strother, D., additional, Lafay-Cousin, L., additional, Eisenstat, D., additional, Fryer, C., additional, Hukin, J., additional, Hsu, M., additional, Lasky, J., additional, Moore, T., additional, Liau, L., additional, Davidson, T., additional, Prins, R., additional, Hassal, T., additional, Baugh, J., additional, Kirkendall, J., additional, Doughman, R., additional, Leach, J., additional, Jones, B., additional, Miles, L., additional, Hargrave, D., additional, Jacques, T., additional, Savage, S., additional, Saunders, D., additional, Wallace, R., additional, Flutter, B., additional, Morgenestern, D., additional, Blanco, E., additional, Howe, K., additional, Lowdell, M., additional, Samuel, E., additional, Michalski, A., additional, Anderson, J., additional, Arakawa, Y., additional, Umeda, K., additional, Watanabe, K.-i., additional, Mizowaki, T., additional, Hiraoka, M., additional, Hiramatsu, H., additional, Adachi, S., additional, Kunieda, T., additional, Takagi, Y., additional, Miyamoto, S., additional, Venneti, S., additional, Santi, M., additional, Felicella, M. M., additional, Sullivan, L. M., additional, Dolgalev, I., additional, Martinez, D., additional, Perry, A., additional, Lewis, P. W., additional, Allis, D. C., additional, Thompson, C. B., additional, and Judkins, A. R., additional

Published
2014
Full Text
View/download PDF

34. (219) - Redefining Primary Graft Dysfunction after Lung Transplantation

Author

Cantu, E., Diamond, J., Nellen, J., Beduhn, B., Suzuki, Y., Borders, C., Lasky, J., Schaufler, C., Shah, R., Porteous, M., Lederer, D.J., Kawut, S.M., Arcasoy, S., Palmer, S.M., Snyder, L., Hartwig, M.G., Lama, V.N., Crespo, M., Wille, K., Orens, J., Shah, P.D., Weinacker, A., Ware, L.B., Bellamy, S.L., and Christie, J.D.

Published
2016
Full Text
View/download PDF

35. LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY

Author

Yang, F. H., primary, Zhang, B., additional, Zhou, D. J., additional, Bie, L., additional, Tom, M. W., additional, Drummond, D. C., additional, Nicolaides, T., additional, Mueller, S., additional, Banerjee, A., additional, Park, J. W., additional, Prados, M. D., additional, James, D. C., additional, Gupta, N., additional, Hashizume, R., additional, Strohbehn, G. W., additional, Zhou, J., additional, Fu, M., additional, Patel, T. R., additional, Piepmeier, J. M., additional, Saltzman, W. M., additional, Xie, Q., additional, Johnson, J., additional, Bradley, R., additional, Ascierto, M. L., additional, Kang, L., additional, Koeman, J., additional, Marincola, F. M., additional, Briggs, M., additional, Tanner, K., additional, Vande Woude, G. F., additional, Tanaka, S., additional, Klofas, L. K., additional, Wakimoto, H., additional, Borger, D. R., additional, Iafrate, A. J., additional, Batchelor, T. T., additional, Chi, A. S., additional, Madhankumar, A. B., additional, Slagle-Webb, B., additional, Rizk, E., additional, Harbaugh, K., additional, Connor, J. R., additional, Sarkar, G., additional, Curran, G. L., additional, Jenkins, R. B., additional, Kurozumi, K., additional, Ichikawa, T., additional, Onishi, M., additional, Fujii, K., additional, Ishida, J., additional, Shimazu, Y., additional, Date, I., additional, Ebsworth, K., additional, Walters, M. J., additional, Ertl, L. S., additional, Wang, Y., additional, Berahovich, R. D., additional, Zhang, P., additional, Powers, J. P., additional, Liu, S.-C., additional, Al Omran, R., additional, Sullivan, T. J., additional, Jaen, J. C., additional, Brown, M., additional, Schall, T. J., additional, Yusuke, N., additional, Shimizu, S., additional, Shishido-Hara, Y., additional, Shiokawa, Y., additional, Nagane, M., additional, Wang, J., additional, Sai, K., additional, Chen, F.-R., additional, Chen, Z.-P., additional, Shi, Z., additional, Zhang, J., additional, Zhang, K., additional, Han, L., additional, Chen, L., additional, Qian, X., additional, Zhang, A., additional, Wang, G., additional, Jia, Z., additional, Pu, P., additional, Kang, C., additional, Kong, L.-Y., additional, Doucette, T. A., additional, Ferguson, S. D., additional, Hachem, J., additional, Yang, Y., additional, Wei, J., additional, Priebe, W., additional, Fuller, G. N., additional, Qiao, W., additional, Rao, G., additional, Heimberger, A. B., additional, Chen, P.-Y., additional, Ozawa, T., additional, Drummond, D., additional, Santos, R., additional, Torre, J. D., additional, Ng, C., additional, Lepe, E. L., additional, Butowski, N., additional, Prados, M., additional, Bankiewicz, K., additional, James, C. D., additional, Cheng, Z., additional, Gong, Y., additional, Ma, Y., additional, Muller-Knapp, S., additional, Knapp, S., additional, Antonio Chiocca, E., additional, Kaur, B., additional, Yu, J. S., additional, Judkowski, V., additional, Bunying, A., additional, Ji, J., additional, Li, Z., additional, Bender, J., additional, Pinilla, C., additional, Srinivasan, V., additional, Dombovy-Johnson, M., additional, Carson-Walter, E., additional, Walter, K., additional, Xu, Z., additional, Popp, B., additional, Schlesinger, D., additional, Gray, L., additional, Sheehan, J., additional, Keir, S. T., additional, Friedman, H. S., additional, Bigner, D. D., additional, Kut, C., additional, Tyler, B., additional, McVeigh, E., additional, Li, X., additional, Herzka, D., additional, Grossman, S., additional, Lasky, J. L., additional, Panosyan, E., additional, Meisen, W. H., additional, Hardcastle, J., additional, Wojton, J., additional, Wohleb, E., additional, Alvarez-Breckenridge, C., additional, Nowicki, M., additional, Godbout, J., additional, Lee, S. Y., additional, Sheehan, J. M., additional, Yin, S., additional, Kaluz, S., additional, Devi, S. N., additional, de Noronha, R., additional, Nicolaou, K. C., additional, Van Meir, E. G., additional, Lachowicz, J. E., additional, Demeule, M., additional, Che, C., additional, Tripathy, S., additional, Jarvis, S., additional, Currie, J.-C., additional, Regina, A., additional, Nguyen, T., additional, Castaigne, J.-P., additional, Zielinska-Chomej, K., additional, Mohanty, C., additional, Viktorsson, K., additional, Lewensohn, R., additional, Driscoll, J. J., additional, Alsidawi, S., additional, Warnick, R. E., additional, Rixe, O., additional, deCarvalho, A. C., additional, Irtenkauf, S., additional, Hasselbach, L., additional, Xin, H., additional, Mikkelsen, T., additional, Sherman, J. H., additional, Siu, A., additional, Volotskova, O., additional, Keidar, M., additional, Gibo, D. M., additional, Dickinson, P., additional, Robertson, J., additional, Rossmeisl, J., additional, Debinski, W., additional, Nair, S., additional, Schmittling, R., additional, Boczkowski, D., additional, Archer, G., additional, Sampson, J. H., additional, Mitchell, D. A., additional, Miller, I. S., additional, Didier, S., additional, Murray, D. W., additional, Issaivanan, M., additional, Coniglio, S. J., additional, Segall, J. E., additional, Al-Abed, Y., additional, Symons, M., additional, Fotovati, A., additional, Hu, K., additional, Triscott, J., additional, Bacha, J., additional, Brown, D. M., additional, Dunn, S. E., additional, Daniels, D. J., additional, Peterson, T. E., additional, Dietz, A. B., additional, Knutson, G. J., additional, Parney, I. F., additional, Diaz, R. J., additional, Golbourn, B., additional, Picard, D., additional, Smith, C., additional, Huang, A., additional, Rutka, J., additional, Saito, N., additional, Fu, J., additional, Yao, J., additional, Wang, S., additional, Koul, D., additional, Yung, W. K. A., additional, Yuan, Y., additional, Sulman, E. P., additional, Colman, H., additional, Lang, F. F., additional, Slat, E. A., additional, Herzog, E. D., additional, Rubin, J. B., additional, Carminucci, A. S., additional, Amendolara, B., additional, Leung, R., additional, Lei, L., additional, Canoll, P., additional, Bruce, J. N., additional, Wojton, J. A., additional, Chu, Z., additional, Kwon, C.-H., additional, Chow, L. M., additional, Palascak, M., additional, Franco, R., additional, Bourdeau, T., additional, Thornton, S., additional, Qi, X., additional, Kitange, G. J., additional, Mladek, A. C., additional, Su, D., additional, Carlson, B. L., additional, Schroeder, M. A., additional, Pokorny, J. L., additional, Bakken, K. K., additional, Gupta, S. K., additional, Decker, P. A., additional, Wu, W., additional, Sarkaria, J. N., additional, Oddou, M. P., additional, Mollard, A., additional, Call, L. T., additional, Vakayalapati, H., additional, Warner, S. L., additional, Sharma, S., additional, Bearss, D. J., additional, Chen, T. C., additional, Cho, H., additional, Wang, W., additional, Hofman, F. M., additional, Flores, C. T., additional, Snyder, D., additional, Sanchez-Perez, L., additional, Pham, C., additional, Friedman, H., additional, Woolf, E., additional, Abdelwahab, M. G., additional, Turner, G., additional, Preul, M. C., additional, Lynch, A., additional, Rho, J. M., additional, Scheck, A. C., additional, Salphati, L., additional, Heffron, T. P., additional, Alicke, B., additional, Barck, K., additional, Carano, R. A., additional, Cheong, J., additional, Greve, J., additional, Lee, L. B., additional, Nishimura, M., additional, Pang, J., additional, Plise, E. G., additional, Reslan, H. B., additional, Zhang, X., additional, GOuld, S. G., additional, Olivero, A. G., additional, Phillips, H. S., additional, Zadeh, G., additional, Jalali, S., additional, Voce, D., additional, Wei, Z., additional, Shijun, K., additional, Nikolai, K., additional, Josh, W., additional, Clayton, C., additional, Bakhtiar, Y., additional, Alkins, R., additional, Burgess, A., additional, Ganguly, M., additional, Wels, W., additional, Hynynen, K., additional, Li, Y. M., additional, Jun, H., additional, Daniel, V., additional, Walter, H. A., additional, Nakashima, H., additional, Nguyen, T. T., additional, Shalkh, I., additional, Goins, W. F., additional, Chiocca, E. A., additional, Pyko, I. V., additional, Nakada, M., additional, Furuyama, N., additional, Lei, T., additional, Hayashi, Y., additional, Kawakami, K., additional, Minamoto, T., additional, Fedulau, A. S., additional, and Hamada, J.-i., additional

Published
2012
Full Text
View/download PDF

36. PEDIATRICS CLINICAL RESEARCH

Author

Murray, J. C., primary, Rainusso, N., additional, Roberts, R. A., additional, Gomez, A. M., additional, Egler, R., additional, Russell, H., additional, Okcu, M. F., additional, Gururangan, S., additional, Fangusaro, J., additional, Young-Poussaint, T., additional, Lesh, S., additional, Onar, A., additional, Gilbertson, R., additional, Packer, R., additional, McLendon, R., additional, Friedman, H. S., additional, Boyett, J., additional, Kun, L. E., additional, Venkatramani, R., additional, Haley, K., additional, Gilles, F., additional, Sposto, R., additional, Ji, L., additional, Olshefski, R., additional, Garvin, J., additional, Tekautz, T., additional, Kennedy, G., additional, Rassekh, R., additional, Moore, T., additional, Gardner, S., additional, Allen, J., additional, Shore, R., additional, Moertel, C., additional, Atlas, M., additional, Lasky, J., additional, Finlay, J., additional, Valera, E. T., additional, Brassesco, M. S., additional, Scrideli, C. A., additional, Oliveira, R. S., additional, Machado, H. R., additional, Tone, L. G., additional, Finlay, J. L., additional, Kreimer, S., additional, Dagri, J., additional, Grimm, J., additional, Bluml, S., additional, Britt, B., additional, Dhall, G., additional, Brown, R. J., additional, Shah, A., additional, Kapoor, N., additional, Abdel-Azim, H., additional, Rao, A. A. N., additional, Wallace, D., additional, Gajjar, A., additional, Packer, R. J., additional, Pearlman, M. L., additional, Sadighi, Z., additional, Bingham, R., additional, Vats, T., additional, Khatua, S., additional, Ko, R. H., additional, O'Neil, S., additional, Lavey, R. S., additional, Davidson, T. B., additional, Tovar, J., additional, Wong, K., additional, Olch, A., additional, Murray, J. C., additional, Honeycutt, J. H., additional, Donahue, D. J., additional, Head, H. W., additional, Alles, A. J., additional, Ray, A., additional, Pearlman, M., additional, Baskin, J., additional, Qaddoumi, I., additional, Ahchu, M. S., additional, Alabi, S. F., additional, Arambu, I. C., additional, Castellanos, M., additional, Gamboa, Y., additional, Martinez, R., additional, Montero, M., additional, Ocampo, E., additional, Howard, S. C., additional, Broniscer, A., additional, Baker, S. D., additional, Baker, J. N., additional, Panandiker, A. P., additional, Onar-Thomas, A., additional, Chin, T. K., additional, Merchant, T. E., additional, Davidoff, A., additional, Kaste, S. C., additional, Stewart, C. F., additional, Espinoza, J., additional, Patel, N., additional, Jeffrey, A., additional, Torkildson, J., additional, Cornelius, A., additional, Bedros, A., additional, Etzl, M., additional, Pradhan, K., additional, Corbett, R., additional, Sullivan, M., additional, McGowage, G., additional, Puccetti, D., additional, Stein, D., additional, Jasty, R., additional, Antony, R., additional, Patel, M., additional, Wong, K. E., additional, Krieger, M., additional, McComb, G., additional, Sanchez-Lara, P. A., additional, Randolph, L. M., additional, Krieger, M. D., additional, Wu, S., additional, Panigrahy, A., additional, Shimada, H., additional, Erdreich-Epstein, A., additional, Puccetti, D. M., additional, Kennedy, T., additional, Salamat, S., additional, Bradfield, Y., additional, Park, H. J., additional, Yoon, J. H., additional, Ahn, H. S., additional, Shin, H. Y., additional, Kim, S. K., additional, Im, H. J., additional, Ra, Y. S., additional, Won, S. C., additional, Baek, H. J., additional, Sung, K. W., additional, Hah, J. O., additional, Lim, Y. T., additional, Lee, G. S., additional, Lee, Y. H., additional, Kim, H. S., additional, Park, J. K., additional, Kim, M. K., additional, Park, J. E., additional, Chung, N. G., additional, Choi, H. S., additional, Campen, C. J., additional, Fisher, P. G., additional, Ruge, M. I., additional, Simon, T., additional, Suchorska, B., additional, Lehrke, R., additional, Hamisch, C., additional, Koerber, F., additional, Treuer, H., additional, Berthold, F., additional, Sturm, V., additional, Voges, J., additional, Kirsch, M., additional, Lindner, C., additional, and Schackert, G., additional

Published
2011
Full Text
View/download PDF

38. Index of Suspicion

Author

Bekmezian, A., primary, Lasky, J. L., additional, Osman, S., additional, Kaddurah, A. K., additional, Varela, A. M. S., additional, Velez, K., additional, and Alvarez, O., additional

Published
2009
Full Text
View/download PDF

41. Reversible binding of platelet-derived growth factor-AA, -AB, and -BB isoforms to a similar site on the 'slow' and 'fast' conformations of alpha 2-macroglobulin

Author

Goodell, A L, Lasky, J A, Hoffman, M R, and Bonner, J C

Abstract

The mechanism by which the platelet-derived growth factor (PDGF)-binding protein, alpha 2-macroglobulin (alpha 2M), modulates PDGF bioactivity is unknown, but could involve reversible PDGF-alpha 2M binding. Herein we report that greater than 70% of 125I-PDGF-BB or -AB complexed to alpha 2M was dissociated by SDS-denaturation followed by SDS-polyacrylamide gel electrophoresis, i.e. most of the binding was noncovalent. Reduction of the PDGF.alpha 2M complex following denaturation dissociated the cytokine from alpha 2M by greater than 90%, suggesting covalent disulfide bond formation. Approximately 50% of the growth factor was dissociated by lowering the pH from 7.5 to 4.0. 125I-PDGF-BB bound alpha 2M in a time-dependent manner (t1/2 = approximately 1 h), reaching equilibrium after 4 h. The 125I-PDGF.BB/alpha 2M complex dissociated more slowly (t1/2 = approximately 2.5 h). "Slow" and "fast" alpha 2M bound nearly equal amounts of PDGF-AB or -BB. Trypsin treatment converted PDGF-BB/alpha 2M complex to the fast conformation but did not release bound 125I-PDGF-BB. All PDGF-isoforms (AA, -AB, and -BB) competed for binding with 125I-PDGF-BB binding to slow alpha 2M and fast alpha 2M-methylamine by 65-80%. Other cytokines that bind alpha 2M (transforming growth factor-beta 1 and -beta 2, tumor necrosis factor-alpha, basic fibroblast growth factor, interleukin -1 beta, and -6) did not compete for 125I-PDGF-BB binding slow alpha 2M, but transforming growth factor-beta 1 and basic fibroblast growth factor inhibited 125I-PDGF-BB binding alpha 2M-methylamine by 30-50%. The reversible nature of the PDGF.alpha 2M complex could allow for targeted PDGF release near mesenchymal cells which possess PDGF receptors.

Published
1992
Full Text
View/download PDF

49. Mainstreaming of the SOI technology

Author

Shahidi, G., primary, Lo, H.-S., additional, Maloney, M., additional, Moy, D., additional, Rausch, W., additional, Sadana, D., additional, Schepis, D., additional, Sherony, M., additional, Sleight, J.W., additional, Wagner, L.F., additional, Wu, K., additional, Ajmera, A., additional, Davari, B., additional, Chen, T.C., additional, Assaderaghi, F., additional, Bolam, R., additional, Bryant, A., additional, Coffey, M., additional, Hovel, H., additional, Lasky, J., additional, and Leobandung, E., additional

Published
1999
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results